Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
Spain’s Picos de Europa: What to see and do in ‘the world’s most beautiful place’ - 2Radiated Tortoise Faces Rapid Decline in Madagascar
- 3A Concise History Of The Entertainment world
- 4Exploring the Difficulties of Beginning a Family: Individual Experiences
- 5Artemis II live updates: NASA's historic moon mission set to make lunar flyby today
- Vote In favor of Your Favored Web based Dating Application
- Finding the Universe of Workmanship: Individual Encounters in Imagination
- Vote In favor of Your Favored Shades
- Nations for Rock Climbing
- Step by step instructions to Utilize Open Record Rewards for Your Potential benefit
- Opening Achievement: 8 Methodologies for Compelling Using time productively
- NASA, in a rare move, cuts space station mission short after an astronaut's medical issue
- OECD: Iran war dampening global growth
- Investigating the Advantages of a Bank account: A Complete Aide
